<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0" xmlns:media="http://search.yahoo.com/mrss/" xmlns:ynews="http://news.yahoo.com/rss/">
    <channel>
        <title>Nova Reader - Subject</title>
        <link>https://www.novareader.co</link>
        <description>Default RSS Feed</description>
        <language>en-us</language>
        <copyright>Newgen KnowledgeWorks</copyright>
        <item>
            <title><![CDATA[Covid Proof Self‐Management Training for Caregivers of Patients with Parkinson's Disease]]></title>
            <media:thumbnail url="https://storage.googleapis.com/nova-demo-unsecured-files/unsecured/content-1766030204520-405db7d6-800c-40cb-9e91-03f8c0424701/cover.png"></media:thumbnail>
            <link>https://www.novareader.co/book/isbn/10.1002/mds.28457</link>
            <description><![CDATA[]]></description>
            <pubDate><![CDATA[2020-12-27T00:00]]></pubDate>
        </item><item>
            <title><![CDATA[Hydrocephalus Complicating Intrathecal Antisense Oligonucleotide Therapy for Huntington's Disease]]></title>
            <media:thumbnail url="https://storage.googleapis.com/nova-demo-unsecured-files/unsecured/content-1765935009135-6e9adbc3-e3d6-4ef5-985c-b9956a873224/cover.png"></media:thumbnail>
            <link>https://www.novareader.co/book/isbn/10.1002/mds.28359</link>
            <description><![CDATA[]]></description>
            <pubDate><![CDATA[2020-10-30T00:00]]></pubDate>
        </item><item>
            <title><![CDATA[Hydrocephalus Complicating Intrathecal Antisense Oligonucleotide Therapy for Huntington's Disease]]></title>
            <media:thumbnail url="https://storage.googleapis.com/nova-demo-unsecured-files/unsecured/content-1765935009135-6e9adbc3-e3d6-4ef5-985c-b9956a873224/cover.png"></media:thumbnail>
            <link>https://www.novareader.co/book/isbn/10.1002/mds.28359</link>
            <description><![CDATA[]]></description>
            <pubDate><![CDATA[2020-10-30T00:00]]></pubDate>
        </item><item>
            <title><![CDATA[Adenosine A<sub>2A</sub> Receptor Occupancy by Long‐Term Istradefylline Administration in Parkinson's Disease]]></title>
            <media:thumbnail url="https://storage.googleapis.com/nova-demo-unsecured-files/unsecured/content-1765934505415-b9f9e1b9-31f5-4ce9-b2c9-14854c610995/cover.png"></media:thumbnail>
            <link>https://www.novareader.co/book/isbn/10.1002/mds.28378</link>
            <description><![CDATA[]]></description>
            <pubDate><![CDATA[2020-11-16T00:00]]></pubDate>
        </item><item>
            <title><![CDATA[Adenosine A<sub>2A</sub> Receptor Occupancy by Long‐Term Istradefylline Administration in Parkinson's Disease]]></title>
            <media:thumbnail url="https://storage.googleapis.com/nova-demo-unsecured-files/unsecured/content-1765934505415-b9f9e1b9-31f5-4ce9-b2c9-14854c610995/cover.png"></media:thumbnail>
            <link>https://www.novareader.co/book/isbn/10.1002/mds.28378</link>
            <description><![CDATA[]]></description>
            <pubDate><![CDATA[2020-11-16T00:00]]></pubDate>
        </item>
    </channel>
</rss>